Used in the synthesis of boron-containing pharmaceuticals, particularly in the development of proteasome inhibitors for cancer treatment. Its boronic acid moiety enables reversible binding to active site residues in enzymes, making it valuable in targeted therapies. Also employed in Suzuki-Miyaura cross-coupling reactions as an intermediate for constructing biaryl compounds in medicinal chemistry. Shows potential in radiopharmaceuticals due to boron's neutron capture properties.